Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Open clinical trial data for all? A view from regulators.
Eichler HG, Abadie E, Breckenridge A, Leufkens H, Rasi G. Eichler HG, et al. Among authors: abadie e. PLoS Med. 2012;9(4):e1001202. doi: 10.1371/journal.pmed.1001202. Epub 2012 Apr 10. PLoS Med. 2012. PMID: 22505851 Free PMC article.
Regulators, payers, and prescribers: can we fill the gaps?
Pignatti F, Luria X, Abadie E, Eichler HG. Pignatti F, et al. Among authors: abadie e. Lancet Oncol. 2011 Sep;12(10):930-1. doi: 10.1016/S1470-2045(11)70229-7. Lancet Oncol. 2011. PMID: 21958501 No abstract available.
New drug approval success rate in Europe in 2009.
Eichler HG, Aronsson B, Abadie E, Salmonson T. Eichler HG, et al. Among authors: abadie e. Nat Rev Drug Discov. 2010 May;9(5):355-6. doi: 10.1038/nrd3169. Nat Rev Drug Discov. 2010. PMID: 20431561 No abstract available.
Safe drugs and the cost of good intentions.
Eichler HG, Abadie E, Raine JM, Salmonson T. Eichler HG, et al. Among authors: abadie e. N Engl J Med. 2009 Apr 2;360(14):1378-80. doi: 10.1056/NEJMp0900092. N Engl J Med. 2009. PMID: 19339718 Free article. No abstract available.
Fifty years after thalidomide; what role for drug regulators?
Eichler HG, Abadie E, Baker M, Rasi G. Eichler HG, et al. Among authors: abadie e. Br J Clin Pharmacol. 2012 Nov;74(5):731-3. doi: 10.1111/j.1365-2125.2012.04255.x. Br J Clin Pharmacol. 2012. PMID: 22369072 Free PMC article. No abstract available.
The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use.
Pean E, Klaar S, Berglund EG, Salmonson T, Borregaard J, Hofland KF, Ersbøll J, Abadie E, Giuliani R, Pignatti F. Pean E, et al. Among authors: abadie e. Clin Cancer Res. 2012 Sep 1;18(17):4491-7. doi: 10.1158/1078-0432.CCR-11-3075. Epub 2012 Jul 24. Clin Cancer Res. 2012. PMID: 22829199
The European Medicines Agency review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: summary of the Scientific Assessment of the Committee for medicinal products for human use (CHMP).
Matt P, van Zwieten-Boot B, Calvo Rojas G, Ter Hofstede H, Garcia-Carbonero R, Camarero J, Abadie E, Pignatti F. Matt P, et al. Among authors: abadie e. Oncologist. 2011;16(10):1451-7. doi: 10.1634/theoncologist.2011-0224. Epub 2011 Sep 30. Oncologist. 2011. PMID: 21963999 Free PMC article. Review.
The European Medicines Agency review of cabazitaxel (Jevtana®) for the treatment of hormone-refractory metastatic prostate cancer: summary of the scientific assessment of the committee for medicinal products for human use.
Pean E, Demolis P, Moreau A, Hemmings RJ, O'Connor D, Brown D, Shepard T, Abadie E, Pignatti F. Pean E, et al. Among authors: abadie e. Oncologist. 2012;17(4):543-9. doi: 10.1634/theoncologist.2011-0364. Epub 2012 Apr 3. Oncologist. 2012. PMID: 22477727 Free PMC article. Review.
124 results